Cargando…
Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge
Autores principales: | Tortajada, C., Navarro, A., Andreu-Ballester, J. C., Mayor, A., Añón, S., Flores, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754532/ https://www.ncbi.nlm.nih.gov/pubmed/35023003 http://dx.doi.org/10.1007/s11739-021-02895-6 |
Ejemplares similares
-
Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009) -
Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010) -
Eating disorder symptomatology and substance use disorders: Prevalence and shared risk in a population based twin sample
por: Baker, Jessica H, et al.
Publicado: (2010) -
COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine
por: Polosa, Riccardo, et al.
Publicado: (2020) -
Choline: The Underconsumed and Underappreciated Essential Nutrient
por: Wallace, Taylor C., et al.
Publicado: (2018)